You are in: eMedicine Specialties > Dermatology > DISEASES OF THE ADNEXA Keratosis PilarisArticle Last Updated: Mar 7, 2008AUTHOR AND EDITOR INFORMATIONAuthor: Nili N Alai, MD, FAAD, Assistant Clinical Professor, Department of Dermatology, Clinical Faculty and Preceptor, Department of Family Practice, University of California at Irvine; Clinical Faculty and Preceptor, Department of Family Practice, Downey Medical Center Residency Training; CEO, The Skin Center, Mission Viejo and Laguna Hills, California Nili N Alai is a member of the following medical societies: American Academy of Dermatology, American College of Mohs Micrographic Surgery and Cutaneous Oncology, American Society for Laser Medicine and Surgery, American Society of Cosmetic Dermatology and Aesthetic Surgery, and Women's Dermatologic Society Coauthor(s): Raul Del Rosario, MD, Consulting Staff, Surgical Pathology and Dermatopathology, South Coast Medical; Azalea Saemi, MBA, University of Vermont; Paimon Dehghanian, Georgia Tech University; Arash Michael Saemi, BS, University of Vermont College of Medicine Editors: Günter Burg, MD, Professor and Chairman Emeritus, Department of Dermatology, University of Zürich School of Medicine; Delegate of The Foundation for Modern Teaching and Learning in Medicine Faculty of Medicine, University of Zürich, Switzerland; Michael J Wells, MD, Associate Professor, Department of Dermatology, Texas Tech University Health Sciences Center; Rosalie Elenitsas, MD, Associate Professor of Dermatology, University of Pennsylvania School of Medicine; Director, Penn Cutaneous Pathology Services, Department of Dermatology, University of Pennsylvania Health System; Joel M Gelfand, MD, MSCE, Medical Director, Clinical Studies Unit, Assistant Professor, Department of Dermatology, Associate Scholar, Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania; Dirk M Elston, MD, Director, Department of Dermatology, Geisinger Medical Center Author and Editor Disclosure Synonyms and related keywords: KP, hyperkeratosis, folliculocentric keratotic papules, follicular keratotic papules, atopic dermatitis, ichthyosis vulgaris, excessive accumulation of keratin, benign skin lesion, gooseflesh appearance, erythema, chicken skin bumps INTRODUCTIONBackgroundKeratosis pilaris (KP) is a genetic disorder of keratinization of hair follicles of the skin. It is an extremely common benign condition that manifests as small, rough folliculocentric keratotic papules, often described as chicken bumps, chicken skin, or goose bumps, in characteristic areas of the body, particularly the outer-upper arms and thighs. Although no clear etiology has been defined, KP is often described in association with other dry skin conditions such as ichthyosis vulgaris, xerosis, and, less commonly, with atopic dermatitis, including conditions of asthma and allergies. See Ichthyosis Vulgaris, Hereditary and Acquired and Atopic Dermatitis for more information. PathophysiologyKP is a genetically based disorder of hyperkeratinization of the skin. The excess formation and/or buildup of keratin is thought to cause the abrasive goose-bump texture of the skin. The process of keratinization (the formation of epidermal skin) is faulty. One theory is that surplus skin cells build up around individual hair follicles. The individual follicular bumps are often caused by a hair that is unable to reach the surface and becomes trapped beneath the keratin debris. Often, patients develop mild erythema around the hair follicles, which is indicative of the inflammatory condition. Often, a small, coiled hair can be seen beneath the papule. Not all the bumps have associated hairs underneath. Papules are thought to arise from excessive accumulation of keratin at the follicular orifice. FrequencyInternationalKP is overall a very common condition and is present worldwide. KP affects 50-80% of adolescents and approximately 40% of adults worldwide. Mortality/MorbidityKP is not associated with increased mortality or morbidity. Often, patients are bothered by the cosmetic appearance of their skin and its rough, gooseflesh texture. KP is present in otherwise healthy individuals and does not have any long-term health implications. RaceKP has no widely described racial predilection or predominance. It is commonly noted worldwide in persons of all races. SexBoth sexes are affected by KP, but females may be affected more frequently than males. AgeAge of onset is often within the first decade of life; symptoms particularly intensify during puberty. However, KP may manifest in persons of any age and is common in young children. Some believe individuals can outgrow the disorder by early adulthood, but often this is not the case. CLINICALHistoryPatients often report a rough texture (gooseflesh appearance) and overall poor cosmetic appearance of their skin. Eruption is usually asymptomatic, except for occasional pruritus. PhysicalPhysical findings are limited to the skin. Upon gross examination, the skin of the outer upper arms and thighs is frequently affected. The skin is described as chicken skin or goose bumps. Often, 10-100 very small slightly rough bumps are scattered in an area. Palpation may reveal a fine, sandpaperlike texture to the area. Some of the bumps may be slightly red or have an accompanying light-red halo indicating inflammation. In some instances, scratching away the surface of some bumps may reveal a small, coiled hair. Small (up to 1-2 mm) folliculocentric keratotic papules are noted (see Media File 1). These are small bumps centered on small hair follicles. Some associated inflammation (erythema) may be present, and lesions may be the color of the skin. Often, a small, coiled hair can be seen beneath the papule. In other instances, a keratin plug or pimplelike material may be expressed from each bump. Pustules and cysts are fairly rare. Commonly involved areas include posterolateral upper arms (see Media File 2), anterior thighs, buttocks, and facial cheeks. The single most characteristic area in KP is the upper outer arms. CausesThe etiology of KP is not fully known. The definite association of hyperkeratinization has been established. Of those affected, 50-70% have a genetic predisposition. Dry skin conditions seem to exacerbate the disease. Symptoms generally tend to worsen in winter and improve in summer. Common associations include a family history of KP, ichthyosis, or atopic dermatitis.3 DIFFERENTIALSAcne Vulgaris Atopic Dermatitis Eruptive Vellus Hair Cysts Erythromelanosis follicularis faciei et colli Folliculitis Keratosis Follicularis (Darier Disease) Kyrle Disease Lichen Nitidus Lichen Spinulosus Milia Perforating Folliculitis Pityriasis Rubra Pilaris Trichostasis Spinulosa
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Drug Name | Tretinoin (Retin-A, Avita) |
|---|---|
| Description | Inhibits microcomedo formation and eliminates lesions present. Makes keratinocytes in sebaceous follicles less adherent and easier to remove. Available as 0.025%, 0.05%, and 0.1% creams. Available also as 0.01%, 0.025%, 0.04%, and 0.1% gels. |
| Adult Dose | Begin with lowest tretinoin formulation and increase as tolerated; apply hs or qod; decrease frequency of application if irritation develops |
| Pediatric Dose | <12 years: Not established >12 years: Administer as in adults |
| Contraindications | Documented hypersensitivity to tretinoin or parabens |
| Interactions | Toxicity increases with coadministration of benzoyl peroxide, salicylic acid, and resorcinol; avoid topical sulfur, resorcinol, salicylic acid, other keratolytics, abrasives, astringents, spices, and lime |
| Pregnancy | C - Fetal risk revealed in studies in animals but not established or not studied in humans; may use if benefits outweigh risk to fetus D - Fetal risk shown in humans; use only if benefits outweigh risk to fetus |
| Precautions | Photosensitivity may occur with excessive sunlight exposure; caution in eczema; do not apply to mucous membranes, mouth, and angles of nose |
Normal constituent of tissues and blood. Act as humectants when applied topically and may decrease corneocyte cohesion.
| Drug Name | Ammonium lactate lotion (AmLactin, Lac Hydrin) |
|---|---|
| Description | Indicated for treatment of ichthyosis vulgaris and xerosis. Contains lactic acid, an alpha-hydroxy acid that has keratolytic action, thus facilitating release of comedones. Causes disadhesion of corneocytes. Use 12% cream or lotion. |
| Adult Dose | Apply bid to affected skin |
| Pediatric Dose | <12 years: Not established >12 years: Apply as in adults |
| Contraindications | Documented hypersensitivity |
| Interactions | None reported |
| Pregnancy | B - Fetal risk not confirmed in studies in humans but has been shown in some studies in animals |
| Precautions | May sting or cause pain if applied to broken skin; may cause irritation with erythema, burning, and peeling if applied to face at 12% concentration; avoid contact with eyes, mucous membranes, and lips; minimize sun exposure because of possibility of heightened photosensitivity |
| Drug Name | Urea |
|---|---|
| Description | Promotes hydration and removal of excess keratin in conditions of hyperkeratosis. Available in 10-40% concentrations. |
| Adult Dose | Apply prn to affected areas |
| Pediatric Dose | 10-20% concentrations acceptable in adolescents; caution with 30-40% concentrations in pediatric patients Apply bid |
| Contraindications | Documented hypersensitivity; severely impaired renal function, active intracranial bleeding, marked dehydration, frank liver failure; infusion into veins of lower extremities in elderly may cause phlebitis and thrombosis |
| Interactions | May decrease effects of lithium |
| Pregnancy | D - Fetal risk shown in humans; use only if benefits outweigh risk to fetus |
| Precautions | Do not use if intracranial bleeding present, unless prior to surgical intervention to control hemorrhage (reduction of brain edema by urea may result in reactivation of intracranial bleeding); may increase risk of venous thrombosis and hemoglobinuria in hypothermic patients; caution in renal impairment |
| Drug Name | Tazarotene (Tazorac) |
|---|---|
| Description | Receptor-selective retinoid is a synthetic retinoid prodrug that is rapidly converted into tazarotenic acid. Because use of tretinoin often is hampered by its irritancy, this product may be advantageous. Available as 0.05% and 0.1% cream or gel. |
| Adult Dose | Apply 0.05% gel every other night for 2 wk initially, then may increase to nightly as tolerated |
| Pediatric Dose | Not established |
| Contraindications | Documented hypersensitivity |
| Interactions | Do not use concomitantly with dermatologic drugs or cosmetics that have a strong drying effect on the skin (eg, salicylic acid, benzoyl peroxide, astringents) |
| Pregnancy | X - Contraindicated; benefit does not outweigh risk |
| Precautions | May cause burning or stinging sensations; discontinue if excessive irritation; rinse thoroughly if contact with eyes, eyelids, or mouth; may cause severe irritation in eczematous skin; photosensitivity may occur |
| Drug Name | Adapalene (Differin) |
|---|---|
| Description | Modulates cellular differentiation, inflammation, and keratinization. May be tolerated by individuals who cannot tolerate tretinoin creams. A therapeutic response can be expected following 8-12 wk of therapy. Available as 0.1% gel or solution or 0.3% gel. |
| Adult Dose | Apply hs; some patients may tolerate bid dosing |
| Pediatric Dose | Not established |
| Contraindications | Documented hypersensitivity |
| Interactions | None reported |
| Pregnancy | C - Fetal risk revealed in studies in animals but not established or not studied in humans; may use if benefits outweigh risk to fetus |
| Precautions | Avoid contact with mucous membranes, eyes, mouth, and nostrils; avoid exposure to sunlight and sunlamps; dryness of skin, scaling, erythema, burning, and pruritus may occur |
Measures should be taken to prevent excessive skin dryness. Mild soaps and cleansers should be used. Frequent application of emollients is very beneficial.
Complications are infrequent. However, postinflammatory hypopigmentation or hyperpigmentation and scarring may occur.
Overall prognosis is good. Many cases resolve with increasing age. However, others may persist into late adulthood with intermittent exacerbations and remissions.
Patient education should focus on the tendency for chronicity of the condition and the need for ongoing maintenance therapy. Patients should also be advised that the condition is not contagious and is not a threat to their overall health. For excellent patient education resources, visit eMedicine's Skin, Hair, and Nails Center.
| Media file 1: Close-up view of keratosis pilaris. Keratotic follicular-based erythematous papules are noted on upper arm. | |
![]() | View Full Size Image | Media type: Photo |
| Media file 2: Keratosis pilaris in characteristic location on outer upper arm of a 30-year-old woman. | |
![]() | View Full Size Image | Media type: Photo |
Article Last Updated: Mar 7, 2008